Nicholas Rockefeller
Urogynecology and Reconstructive Pelvic Surgery · Albuquerque, NMNPI 1699185660
Payments from drug & device makers
Across 19 payments — averaging $690.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$7K
- Boston Scientific$6K
- Medtronic$132
- Axonics, Inc.$69
- Caldera Medical, Inc$21
- Smith+Nephew$14
What the payments were for
- Speaking & faculty fees$5,65043%
- Travel & lodging$370%
- Food & beverage$4403%
- Education$7,00053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $7,029 |
| Boston Scientific | 8 | $5,863 |
| Medtronic | 1 | $132 |
| Axonics, Inc. | 4 | $69 |
| Caldera Medical, Inc | 1 | $21 |
| Smith+Nephew | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$6,000
- Da Vinci Surgical System$1,000
- Advantage System$850
- INTERSTIM$132
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in New Mexicoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 319 | $171,237 |
| GemtesaVibegron | 111 | $68,221 |
| Trospium Chloride | 321 | $12,587 |
| Estradiol | 225 | $10,692 |
| Fosfomycin Tromethamine | 36 | $4,136 |
| Trospium Chloride ErTrospium Chloride | 20 | $2,933 |
| Cephalexin | 278 | $2,766 |
| Solifenacin Succinate | 101 | $2,326 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 102 | $1,991 |
| Oxybutynin Chloride ErOxybutynin Chloride | 69 | $1,564 |
| Tolterodine Tartrate ErTolterodine Tartrate | 21 | $1,248 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 174 | $1,210 |
| Cimetidine | 22 | $1,092 |
| Naloxone Hcl | 11 | $915 |
| Tolterodine Tartrate | 18 | $598 |
Paid to pharmacies, not to this prescriber.
Other urogynecology and reconstructive pelvic surgery in Albuquerque
- Alana WilliamsAlbuquerque$13K
- Brook McFaddenAlbuquerque$5K
- Sarah JeneyAlbuquerque$3K
- Kate MeriwetherAlbuquerque$3K
- Tasha Serna GallegosAlbuquerque$748
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.